circSOD2/miR-502-5p/DNMT3a/SOCS3-JAK2/STAT3/circSOD2 axis, a novel pathway through which JAK2/STAT3 is activated provides promising therapeutic targets against HCC. This evidence concerns the gene DNMT3A and hepatocellular carcinoma.